Can Doug Mills’ photo of a bullet and President Trump be

New Post Public Reply Private Reply Replies (1) Message Board
Steel Reserve
357
Can Doug Mills’ photo of a bullet and President Trump be real? Yes. Here's how...



This morning the world is looking at a picture by Doug Mills, a New York Times photographer, which appears to show a blurred trail of a bullet having passed President Trump or clipped his ear.

Many will be asking themselves "Is it possible to take a picture of a bullet in flight?" The short answer is "Yes", so there is no reason to assume Mills image is a fake.

Taking a photograph of a bullet has been done before, but typically it's done in controlled circumstances – Sweedish photographer captured a picture of biathlete Hanna Öberg, using a Nikon Z 9 which shows the bullet leaving the muzzle of a rifle.

Strand used a "spray and pray" approach with the camera's 120fps stills mode and a shutter of 1/32,000sec, but it was still the result of a good amount of timing and practice getting to grips with the timing of the athlete's firing so the bullet was fired while the image buffer had from to write to.

At 1/32,000sec, however, the 'frozen bullet' – despite some motion blur – is more or less visible for its shape....

Mills, being a professional, will also no doubt have used his burst and full image buffer to capture as many images as possible the moment it became clear something was happening.

With the bright conditions and the camera closely focussed on the President, a nearby passing bullet would be in sharp focus if passing close enough.

The only remaining question as to whether a blur is visible is how fast it was going compared to the shutter speed.

The shooter, identified by the FBI as Thomas Matthew Crooks, used "an AR-style rifle" – which would send a bullet at around 3000ft/sec as it leaves the gun.

A bullet loses speed as it flies, and the shooter was around 600ft from the former President.

According to Politiko, Mills was taking photos with "a Sony camera capable of up to 30fps and 1/8000sec" (though they don't say which one or what setting he was using).

Mills is known to have spoken about why he switched to the Sony a9 (from Canon) in the past (the interview is on the Sony site). We now think he's using a Sony A9iii.

In that case he might have been shooting at 1/8000sec (it was a bright day), but the camera offers up to 120fps bursts and 1/80,000 sec, not that anyone would choose that setting unless planning for a bullet!

Mills has since described the event to the New York Times (subscription required for full story).

The point being that the shutter speeds and ballistic math seems to suggest there is no reason why, in this photo, we're not seeing air displacement from a passing bullet – though since 5 shots were fired it's not clear if it's the one which clipped Trump's ear.

One might expect to see debris in that case, and according to Politiko again, Michael Harrigan, an FBI retiree agress that is could be a bullet but "the angle seems a little low" to be the one to go through the ear.

https://www.yahoo.com/news/doug-mills-photo-b...17659.html




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 26

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
Understanding Voting Rights and Corporate Governance at Valeo

Updated Category News Views 54

Understanding Voting Rights and Corporate Governance at Valeo Valeo, a prominent name in the mobility technology sector, plays an essential role in implementing innovative solutions that contribute to cleaner, safer, and smarter transportation. As a technology partner to automakers and emerging players in the mobility space, the company's advancements are vital for the...

Continue Reading
Transforming Field Service Management Through Strategic Alliances

Updated Category News Views 101

ServicePower and Marcone Appliance Parts Form Strategic Alliance In a notable development, ServicePower, a recognized leader in field service management software, has announced a strategic partnership with Marcone Appliance Parts, a well-established distributor in North America. This collaboration aims to revolutionize how service providers operate by integrating...

Continue Reading
Goldman Sachs Pushes Gold Price Target to Mid-2026

Updated Category News Views 639

Goldman Sachs Updates Gold Price Forecast Goldman Sachs has recently adjusted its predictions on gold prices, extending the expected timeline for reaching $3,000 per ounce to mid-2026. This update signals a significant shift from earlier forecasts that anticipated this milestone as early as December 2025. Factors Influencing the Price Revision The primary reason for this...

Continue Reading
Comcast's Generous $50,000 Donation for Storm Relief Efforts

Updated Category News Views 213

Comcast's Commitment to Community Support Comcast has recently made a poignant statement of support by donating $50,000 to assist nonprofit organizations as they work to aid those affected by destructive storms. This financially targeted initiative is designed to ensure families and businesses get the vital resources they require during challenging times. Donation Purpose...

Continue Reading